ProfileGDS5822 / ILMN_1216098
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 82% 81% 80% 84% 81% 80% 82% 83% 80% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1169.582
GSM1276600PDAC Late Ablation Control 2172.681
GSM1276601PDAC Late Ablation Control 3196.780
GSM1276602PDAC Late Ablation 1221.984
GSM1276603PDAC Late Ablation 2166.281
GSM1276604PDAC Late Ablation 314980
GSM1303940PDAC Late Ablation_anti-CTLA4 1171.182
GSM1303941PDAC Late Ablation_anti-CTLA4 2254.683
GSM1303942PDAC Late Ablation_anti-CTLA4 318080